The Cigna Group(CI)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
CI | 75.64 B | 11.96x | 6.70% | 2.27% | $23.94 | 16.76% | 0.74 | 2.24% | $310.19 | $235.50 |
CVS | 124.32 B | 25.65x | 7.10% | 1.18% | $3.79 | 6.21% | 0.95 | 2.86% | $94.86 | $92.71 |
LH | 26.88 B | 27.60x | 5.80% | 6.99% | $12.01 | 11.73% | 0.79 | 86.00% | $341.07 | $242.07 |
DGX | 26.42 B | 25.69x | 10.20% | 9.19% | $9.32 | 14.60% | 0.81 | 1.42% | $247.19 | $168.97 |
Peer Valuation & Performance Analysis
Peer group analysis for The Cigna Group (CI) compared to its primary competitors (including CVS, LH, DGX) reveals distinct metrics. CI trades at a valuation discount relative to its competitors, with a P/E ratio of 12.0x versus the peer average of 26.3x (representing a 55% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, CI's revenue growth of 6.7% is consistent with the peer average of 7.7%. Additionally, its net margin of 2.3% is below the peer average of 5.8%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• CI ranks #1 in P/E ratio, #3 in revenue growth, and #3 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $284.05 | $286.53 | $280.95 | $286.26 | 1,666,400 | +0.78% |
| 2026-09-02 | $283.10 | $286.81 | $280.70 | $282.84 | 1,493,000 | -0.09% |
| 2026-09-01 | $279.66 | $283.56 | $278.71 | $283.06 | 1,304,800 | +1.22% |
| 2026-08-31 | $278.99 | $278.99 | $275.59 | $276.08 | 1,421,600 | -1.04% |
| 2026-08-28 | $280.68 | $280.68 | $277.65 | $278.88 | 1,602,400 | -0.64% |
| 2026-08-27 | $277.79 | $281.80 | $276.31 | $277.67 | 1,228,600 | -0.04% |
| 2026-08-26 | $279.70 | $286.01 | $279.40 | $280.87 | 1,228,300 | +0.42% |
| 2026-08-25 | $278.87 | $279.55 | $276.25 | $279.32 | 1,644,800 | +0.16% |
| 2026-08-24 | $278.51 | $281.73 | $276.96 | $280.45 | 1,971,700 | +0.70% |
| 2026-08-21 | $274.81 | $279.39 | $274.25 | $277.51 | 2,057,400 | +0.98% |
| 2026-08-20 | $277.24 | $278.80 | $274.04 | $274.41 | 1,088,700 | -1.02% |
| 2026-08-19 | $279.61 | $282.75 | $276.91 | $277.45 | 1,125,700 | -0.77% |
| 2026-08-18 | $278.50 | $282.58 | $277.73 | $278.50 | 920,300 | - |
| 2026-08-17 | $280.00 | $280.12 | $274.61 | $275.33 | 893,500 | -1.67% |
| 2026-08-14 | $278.54 | $283.00 | $277.69 | $282.56 | 895,800 | +1.44% |
Explore More Analysis for CI
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.